AYTU BIOPHARMA, INC Proceeds from Contributed Capital
AYTU BIOPHARMA, INC (AYTU) reported Proceeds from Contributed Capital of $0 for the 6-month period ending 2015-12-31, per its 10-Q filed 2016-02-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2016-02-11
- AYTU BIOPHARMA, INC proceeds from contributed capital for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC proceeds from contributed capital for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC proceeds from contributed capital for the quarter ending 2014-12-31 was $500.00K.
- AYTU BIOPHARMA, INC proceeds from contributed capital for the quarter ending 2014-09-30 was $600.00K.
- AYTU BIOPHARMA, INC proceeds from contributed capital for fiscal 2014 was $637.21K.
- AYTU BIOPHARMA, INC proceeds from contributed capital for fiscal 2009 was $1.76K, a 162.63% increase from fiscal 2008.
- AYTU BIOPHARMA, INC proceeds from contributed capital for fiscal 2008 was $669.00, a 27.68% decline from fiscal 2007.
- AYTU BIOPHARMA, INC proceeds from contributed capital for fiscal 2007 was $925.00, a 52.93% decline from fiscal 2006.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 6 month | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month | Proceeds from Contributed Capital 108 month | Proceeds from Contributed Capital 111 month |
|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-11 | $0.00 10-Q · filed 2016-02-11 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 | |||||
| 2014-12-31 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-11 | $1.10M 10-Q · filed 2016-02-11 | $1.10M derived: sum of 3 quarters · filed 2016-02-11 | |||
| 2014-09-30 | $600.00K 10-Q · filed 2015-11-06 | $600.00K derived: sum of 2 quarters · filed 2015-11-06 | ||||
| 2014-06-30 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | $637.21K 10-K · filed 2015-09-28 | ||||
| 2014-05-31 | $900.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | $2.64K 10-Q · filed 2014-07-10 | $43.36K 10-Q · filed 2014-07-10 | |||
| 2014-03-31 | $637.21K 10-Q · filed 2015-05-19 | |||||
| 2014-02-28 | $1.74K 10-Q · filed 2014-04-11 | $42.46K 10-Q · filed 2014-04-11 | ||||
| 2013-05-31 | $2.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | $5.49K 10-Q · filed 2014-07-10 | ||||
| 2013-02-28 | $3.40K 10-Q · filed 2014-04-11 | |||||
| 2009-08-31 | $1.76K 10-K · filed 2014-11-26 | |||||
| 2008-08-31 | $669.00 10-K · filed 2014-11-26 | |||||
| 2007-08-31 | $925.00 10-K · filed 2014-11-26 | |||||
| 2006-08-31 | $1.97K 10-K · filed 2014-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |